Adagio Therapeutics (NASDAQ:ADGI – Get Rating) is one of 262 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its competitors? We will compare Adagio Therapeutics to related businesses based on the strength of its valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and earnings. Earnings and Valuation This […]